NL-OMON39628已完成3 期
The effect of Caphosol on the development of esophagitis in (N)SCLC patients treated with concurrent chemo/radiotherapy - CARACTER
Amphia Ziekenhuis0 个研究点目标入组 55 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
Trial ended prematurely
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •18 years or older
- •Patients with histologically proven (N)SCLC (all histological subtypes), treated with concurrent chemo- and radiotherapy.
排除标准
- •Concurrent participation in a clinical trial in which the subject is taking or receiving any
- •investigational agent that may affect the frequency, severity or duration of mucositis.
- •Pre-existent esophagitis.
- •Receiving investigational treatment for the prevention or treatment of mucositis.
- •Prior irradiation to the lung or head and neck region.
研究者
相似试验
已完成
不适用
Superior capsular reconstruction of irreparable degenerative rotator cuff tears of the shoulder: a multi-center,comparative, prospective, observational follow-up studyNL-OMON48664Viecuri Medisch Centrum voor Noord-Limburg17
已完成
不适用
An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19dyspnoea10047438HypoxemiaNL-OMON49317niversitair Medisch Centrum Utrecht12
已完成
不适用
Safety and protective efficacy of chemoprophylaxis and sporozoite immunization with Plasmodium falciparum NF135 against homologous and heterologous challenge infection in healthy volunteers in the NetherlandsMalaria infectiePlasmodium falciparum10037072malariaNL-OMON44351Radboud Universitair Medisch Centrum52
已完成
3 期
Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early versus delayed treatment with venglustat (GZ/SAR402671) in patients at risk of rapidly progressive autosomal dominant polycystic kidney disease (ADPKD)kidney diseaseADPKDNL-OMON51229Genzyme Europe BV32
已完成
不适用
First in Human Study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of PPSGG (PN-1007) in anti-MAG neuropathy patients.anti-MAG neuropathyauto-immune10012303NL-OMON49059Polyneuron Pharmaceuticals AG9